In the BioHarmony Drug Report Database

"Preview" Icon

Quinidine polygalacturonate

Cardioquin (quinidine polygalacturonate) is a small molecule pharmaceutical. Quinidine polygalacturonate was first approved as Cardioquin on 1982-01-01. It is used to treat atrial fibrillation, atrial flutter, and cardiac arrhythmias in the USA. It is known to target potassium channel subfamily U member 1, potassium voltage-gated channel subfamily H member 1, potassium voltage-gated channel subfamily H member 5, potassium voltage-gated channel subfamily A member 5, equilibrative nucleoside transporter 4, and potassium voltage-gated channel subfamily A member 7.

 

Trade Name

 

Cardioquin
 

Common Name

 

quinidine polygalacturonate
 

ChEMBL ID

 

CHEMBL1201486
 

Indication

 

atrial fibrillation, atrial flutter, cardiac arrhythmias
 

Drug Class

 

Image (chem structure or protein)

Quinidine polygalacturonate structure rendering